---
schema_version: "secwatch.filing_event.v1"
accession: "0000785161-25-000070"
form_type: "8-K"
ticker: "EHC"
cik: "0000785161"
company_name: "Encompass Health Corp"
filed_at: "2025-09-12T23:59:59+00:00"
generated_at: "2026-05-17T06:48:08.925903+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Encompass Health reaffirms FY2025 guidance during investor meetings

## Summary
- Net operating revenue guidance of $5.88B-$5.98B for FY2025.
- Adjusted EBITDA guided at $1.22B-$1.25B; adjusted EPS $5.12-$5.34.
- Reiteration provided at meetings on Sept 12, Oct 1, and Oct 6, 2025.
- Previous guidance from Aug 4/5, 2025 remains unchanged.

## SEC filing metadata
- accession: 0000785161-25-000070
- form_type: 8-K
- ticker: EHC
- cik: 0000785161
- company_name: Encompass Health Corp
- filed_at: 2025-09-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/785161/000078516125000070/0000785161-25-000070-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/785161/000078516125000070/ehc-20250912.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000785161-25-000070
- JSON: https://secwatch.observer/filing/0000785161-25-000070.json
- Plain text: https://secwatch.observer/filing/0000785161-25-000070.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.